UCSF Voice and Swallowing Center, University of California, San Francisco, San Francisco, California 94115, USA.
Laryngoscope. 2011 Oct;121(10):2191-4. doi: 10.1002/lary.21965. Epub 2011 Sep 6.
OBJECTIVES/HYPOTHESIS: To determine whether temporary vocal fold injection affects the need for permanent medialization laryngoplasty in patients with unilateral vocal fold paralysis (UVFP).
Retrospective chart review.
A total of 175 patients with dysphonia resulting from UVFP were identified. Patients with documented recovery of vocal fold mobility, <9 months of follow-up after diagnosis of UVFP, previous treatment at other institutions, neoplastic disease involving the larynx, or history of radiation to the larynx were excluded. Fifty-four patients met all inclusion/exclusion criteria. Rates of permanent medialization laryngoplasty in patients undergoing vocal fold injection were compared with those of patients who chose observation or voice therapy.
A total of 35% of patients underwent temporary injection medialization, and the remaining 65% chose conservative management. Five of 19 of the temporary injection medialization patients subsequently underwent permanent intervention compared to 23 of 35 of the conservative management group (P = .0131).
UVFP patients who underwent vocal fold injection with an agent intended to provide temporary medialization were statistically significantly less likely to undergo permanent medialization laryngoplasty compared to those patients who were treated with conservative management only.
目的/假设:确定单侧声带麻痹(UVFP)患者的临时声带注射是否会影响永久性声带中部成形术的需求。
回顾性图表审查。
共确定了 175 名因 UVFP 导致发声障碍的患者。排除了声带运动功能恢复记录、诊断为 UVFP 后随访时间<9 个月、在其他机构接受过治疗、喉内肿瘤性疾病或喉放疗史的患者。54 名患者符合所有纳入/排除标准。比较行声带注射的患者与选择观察或语音治疗的患者行永久性声带中部成形术的比率。
共有 35%的患者行临时注射性声带中部成形术,其余 65%的患者选择保守治疗。19 名行临时注射性声带中部成形术的患者中有 5 名(26.3%)随后行永久性干预,而 35 名行保守治疗的患者中有 23 名(65.7%)(P=0.0131)。
与仅接受保守治疗的患者相比,接受旨在提供临时声带中部成形术的药物进行声带注射的 UVFP 患者行永久性声带中部成形术的可能性显著降低。